Integrated continuous downstream process of monoclonal antibody developed by converting the batch platform process based on the process characterization
Biotechnology and Bioengineering · 2024
DOI: 10.1002/bit.28537 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2024. Written by Fuminori Konoike and 2 co-authors. Institution: Manufacturing Technology Association of Biologics, Shin-kawa, Chuo-ku, Japan. Major MEDLINE topics: Antibodies, Monoclonal. Cited 10 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Japan Agency for Medical Research and Development.
Abstract (original language)
A continuous downstream process of monoclonal antibody was developed based on the process characterization. Periodic‐counter current chromatography (PCCC) with two protein A columns was used for the capture step. For low pH virus inactivation (VI), a batch reactor was employed, which can work as a surge (buffer) tank. Flow‐through chromatography (FTC) with two connected columns of different separation modes (anion‐mixed mode and cation exchange) was designed as a polish step. After 24 h PCCC run, the collected pool was processed for VI. After adjusting pH and electric conductivity, the solution was fed to the two connected FTC columns for 24 h. Virus filter was also connected to the exit of the connected‐column. PCCC and FTC were run in parallel. Six runs of different feed rates (0.5–10 L/day) and feed concentrations (1–3.2 g/L) were performed with protein A columns of 1–5 mL and FTC columns of 3–10 mL. The largest run (feed rate 10 L/day, feed concentration 2 g/L) was carried out at a GMP facility with 15 mL protein A columns and 100 mL FTC columns. Good recovery and purity values were obtained for all runs. The process was found to be flexible and stable for feed fluctuations. Only three surge or pool tanks were needed in addition to the final product pool tank.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Manufacturing Technology Association of Biologics, Shin-kawa, Chuo-ku, Japan.
- Biomedical Engineering Center (YUBEC), Graduate School of Science and Technology for Innovation, Yamaguchi University, Ube, Japan.
Funding
- Japan Agency for Medical Research and Development
Cite
APA
Konoike, F., Taniguchi, M., & Yamamoto, S. (2024). Integrated continuous downstream process of monoclonal antibody developed by converting the batch platform process based on the process characterization. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28537
Vancouver
Konoike F, Taniguchi M, Yamamoto S. Integrated continuous downstream process of monoclonal antibody developed by converting the batch platform process based on the process characterization. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28537
BibTeX
@article{Konoike2024,
author = {Konoike, Fuminori and Taniguchi, Masatoshi and Yamamoto, Shuichi},
title = {Integrated continuous downstream process of monoclonal antibody developed by converting the batch platform process based on the process characterization},
journal = {Biotechnology and Bioengineering},
year = {2024},
doi = {10.1002/bit.28537}
}
EUVIMED